Company
Cohort PLC
LON:CHRT
Cohort plc is the parent company of four innovative, agile and responsive businesses operating in defence and related markets. It aims to add real value through the experience and contacts of its senior team while providing a light-touch but effective governance framework. Its objective is to deliver value to shareholders through its four operating subsidiaries: MASS, MCL, SCS and SEA. Cohort is traded in the ISDX Exchange HERE
61 stories · page 1 of 4
Cohort wins more hearing-protection orders from UK Ministry of Defence
They included a tactical hearing protection system for the dismounted close combat user
Archive
Small Cap Wrap - CyanConnode, Crossword Cybersecurity, Cohort and more...
The independent technology Group, today announced an unaudited trading update for its financial year ended 30 April 2021 and outlook for the current financial year. Trading performance for the year ended 30 April 2021 is in line with expect
Archive
Breakfast News - AEX Gold, Scotgold Resources, Nu-Oil & Gas and more...
Dish of the day No Joiners Today. Off the menu No Leavers Today. What’s cooking in the IPO kitchen? Elixirr, a consultancy helping clients in areas such as technological disruption have announced their intention to IPO onto AIM. The placing
Another year gone by in a flash.....
Another year gone by in a flash. Obviously this is written pre election! The end of the year could go horribly wrong with a Corbyn win or a close parliament.A surprisingly excellent year with some good gains and the main thing is I avoided
MaxCyte phase drug making "significant progress"
MCY-M11 is currently in phase I clinical trials in people with difficult-to-treat ovarian cancer and peritoneal mesothelioma
Archive
Breakfast News - Ideagen, Wilmcote Holdings, Tremor International and more...
Set menuAIM:Total number of AIM Companies (Incl Susp):875*Total number of AIM Companies trading:791**as at close of business 08 October 2019Standard List** of Main Market:
Archive
Just when you thought the mess couldn't get any worse it does!
Just when you thought the mess couldn't get any worse it does!The markets do not like uncertainty and it's hard to be a lot more uncertain at the moment.That's why I told beginners at the seminar to go very slowly indeed at the moment till
ReNeuron remains in talks with potential partners
The stem cells specialist has two active clinical trials treating patients respectively for a blindness-causing disease called retinitis pigmentosa and stroke
Investments and investor services
FTSE 100 closes higher as Boris Johnson gets keys to Number 10
London's index of leading shares spent the day in positive territory but gave back gains towards the close